News
Pharmaceutical giant Eli Lilly expanded its Virginia facility investment plans to $5 billion from original $2.1 billion amid ...
Eli Lilly Chief Executive Officer Dave Ricks says a pullback in U.K. biopharmaceutical investments should send a message to U ...
Eli Lilly and Co. (NYSE:LLY) is one of the best defensive stocks to buy, according to Steve Cohen. On September 9, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results